Edition:
United Kingdom

Seikagaku Corp (4548.T)

4548.T on Tokyo Stock Exchange

1,755JPY
23 Jan 2018
Change (% chg)

¥17 (+0.98%)
Prev Close
¥1,738
Open
¥1,739
Day's High
¥1,765
Day's Low
¥1,734
Volume
114,400
Avg. Vol
167,917
52-wk High
¥2,109
52-wk Low
¥1,535

Chart for

About

SEIKAGAKU CORPORATION is principally engaged in the research, development, purchase, manufacture and sale of pharmaceutical products and limulus amebocyte lysate (LAL). The Company operates in two business segments. The Pharmaceutical business segment provides hyaluronan-based medicines for joint function improvement, ophthalmic... (more)
No analyst recommendations are available for .

Overall

Beta: 0.70
Market Cap(Mil.): ¥114,025.90
Shares Outstanding(Mil.): 56.81
Dividend: 13.00
Yield (%): 1.30

Financials

  Industry Sector
P/E (TTM): -- 31.11 16.62
EPS (TTM): -- -- --
ROI: -- 14.89 10.61
ROE: -- 16.37 14.21

BRIEF-Ribomic signs collaborative research contract with SEIKAGAKU

* Says it signed collaborative research contract with SEIKAGAKU CORPORATION

08 Nov 2017

Earnings vs. Estimates